Press Releases Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Delayed Canadian Securities Exchange Other stock markets 03:07:58 2024-05-16 pm EDT			5-day change	1st Jan Change
0.015 ^CAD	-25.00%		-20.00%	-60.00%

Mar. 26	Psyence Group Closes Strategic Restructuring of Its Non-Clinical Business	MT
Mar. 26	An undisclosed buyer completed the acquisition of Mind Health Ltd and Psyence Uk Group Ltd from Psyence Group Inc..	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Psyence : NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	May. 06	PU
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical Partners with Fluence and iNGENū CRO to Train Research Therapists for Phase IIb Psilocybin Trial	Apr. 16	GL
Psyence Group Announces the Closing of the Previously Announced Strategic Restructuring of Its Non-Clinical Business	Mar. 26	AQ
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	Mar. 12	GL
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study	Mar. 12	AQ
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	GL
Psyence Group Provides Corporate Update Following Successful Spac Spin Out of Therapeutic Division	Mar. 11	AQ
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	Jan. 25	GL
Psyence Biomedical Ltd. Approved to List on Nasdaq following Completion of Business Combination Agreement with Newcourt Acquisition Corp	Jan. 25	AQ
Psyence Group Inc Subsidiary Psyence Biomedical Ltd. announces signing of definitive agreement for a convertible note in connection with planned business combination	Jan. 16	GL
Psyence Group Announces Resignation of Board Member	Nov. 20	GL
Canadian Investment Regulatory Organization Trade Resumption - PSYG	Nov. 15	AQ
Canadian Investment Regulatory Organization Trading Halt - PSYG	Nov. 15	AQ
Psyence Group Announces SEC Effectiveness of F-4 for Proposed Business Combination Between Subsidiary and Nasdaq Listed Newcourt Acquisition Corp	Nov. 15	GL
Psyence Production Expands Capability	23-10-30	GL
Psyence Group Announces Closing of Private Placement & Conclusion of Loan Agreement	23-08-21	GL
Psyence Group Announces SEC Registration Filing with NASDAQ SPAC, Newcourt, and Signing of Amended and Restated Business Combination Agreement	23-08-02	GL
Psyence : Corporate Update	23-08-02	PU
Psyence Group Corporate Update	23-07-12	GL
Psyence Appoints Intellectual Property Expert to Its Board of Directors	23-07-11	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Psyence Group Inc.

Equities

PSYG

CA74449Q1063

Press Releases

Filters